Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04560959
Other study ID # LYS-[2020]-051
Secondary ID
Status Not yet recruiting
Phase Phase 1/Phase 2
First received
Last updated
Start date September 20, 2020
Est. completion date December 1, 2021

Study information

Verified date August 2020
Source Xuanwu Hospital, Beijing
Contact P.H. Wei
Phone +86-010-83198252
Email weipenghu@xwhosp.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

By analyzing the SEEG recordings, we explore the range of cortical functional responses to strings of 77.5Hz stimulations delivered by tACS,


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date December 1, 2021
Est. primary completion date May 1, 2021
Accepts healthy volunteers No
Gender All
Age group 14 Years to 60 Years
Eligibility Inclusion Criteria:

- All epileptic patients that would receive the implantation of SEEG electrodes, regardless of the seizure locations;

- There was no metal implantation before;

- Eligible for MRI examination;

- No other lesional neurological disorders;

- Could be well informed by the study protocols.

Exclusion Criteria:

- Suffered from any other mental illnesses prior to the enrollment;

- Those suffering from the serious or unstable organic diseases;

- Pregnant or lactation women, and those who have a plan of pregnant;

- Patients with central nervous system tumors, acute brain injury or infection;

- Skin injured, or allergic to the exposure of the conductive gel;

- Those with implanted devices;

- Those who received modified electrical convulsive therapy, or TMS within the recent one month;

- The score of item 3 (suicidal item) in HAMD-17 equal or greater than 3;

- Enrolled in any other on going trials;

- Other situations evaluated by the researchers as inappropriate to the enrollment

Study Design


Related Conditions & MeSH terms

  • Transcranial Alternating Current Stimulation

Intervention

Device:
tACS
tACS would be performed to epilepsy patients who have already received implantation of the SEEG electrodes

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Xuanwu Hospital, Beijing

Outcome

Type Measure Description Time frame Safety issue
Primary Changes of intracranial activities The change of the power in a band of 0-200 HZ according to the intracranial EEG recording. Within 250 ms immediately after the stimulation.
Secondary Frequency of the epileptic discharges To count the numbers of epileptic discharges within the same duration before and when tACS intervention. 50 minutes during the stimulation and 50 minutes of the interictal baseline before the intervention during the same hour of the day
Secondary Event related potential (ERP) ERP related to cognitive tasks before and immediately after the tACS intervention Baseline: 24 hours before the tACS intervention; Observation: Immediately after the end of the tACS intervention.
See also
  Status Clinical Trial Phase
Recruiting NCT05932706 - Intervention Effect of High Definition Transcranial Alternating Current Stimulation (HD-tACS) on Depressive Disorder N/A
Recruiting NCT04997226 - Cognitive Enhancement in Healthy Elderly People N/A
Recruiting NCT06026826 - Intervention Effect of Transcranial Alternating Current Stimulation(tACS) on Anxiety Disorder N/A
Recruiting NCT06127056 - Intervention Effect of High-Definition Transcranial Alternating Current Stimulation (HD-tACS) on Non-suicidal Self-injury (NSSI) N/A
Recruiting NCT05502822 - High Definition Transcranial Alternating Current Stimulation (HD-tACS) for Post-stroke Aphasia N/A
Completed NCT05907707 - Effects of Gamma-tACS on Memory and Sleep N/A
Not yet recruiting NCT05312359 - Brain Mechanism and Intervention of Executive-control Dysfunction Among Substance Dependents N/A
Completed NCT05809076 - Effects of Gamma-tACS on EEG Periodic Activity N/A